Britanin Unveiled: A Comprehensive Exploration of its Therapeutic Potential
It is concluded that the combined therapy of BRT with chemotherapy and immunotherapy has emerged as a strong candidate for development as a novel anticancer therapy.
2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
It is concluded that the combined therapy of BRT with chemotherapy and immunotherapy has emerged as a strong candidate for development as a novel anticancer therapy.
This review critically evaluates recent advances in indole-based anticancer agents, with particular emphasis on structure–activity relationships (SAR), molecular mechanisms, and target-oriented drug design.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.